Fatty acid composition of brain glycerophospholipids in peroxisomal disorders

Lipids

Volumn 34, Issue 7, 1999, Pages 733-740

  Martinez, Manuela ^a   Mougan, Isabel ^a  

^a Maternity Children's Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ETHANOLAMINE; FATTY ACID; GLYCEROPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE;

ARTICLE; BRAIN DEVELOPMENT; BRAIN LEVEL; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME ACTIVITY; ENZYME DEFICIENCY; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; PHENOTYPE; THIN LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION; ZELLWEGER SYNDROME;

BRAIN; FATTY ACIDS, UNSATURATED; GLYCEROPHOSPHOLIPIDS; HUMANS; PEROXISOMAL DISORDERS;

EID: 0032781202     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-999-0420-6     Document Type: Article

References (30)

1. Bowen, P., Lee, C.S.M., Zellweger, H., and Lindenberg, R. (1964) A Familial Syndrome of Multiple Congenital Defects, Bull. Johns Hopkins Hosp. 114, 402-414.
2. Goldfischer, S., Moore, C.L., Johnson, A.B, Spiro, A.J., Valsmis, M.P., Wisniewski, H.K., Ritch, R.H., Norton, W.T., Rain, I., and Gartner, L.M. (1973) Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome, Science 182, 62-64.
3. Brown, F.R., McAdams, A.J., Cumins, J.W., Konkol, R., Singh, I., Moser, A.B., and Moser, H.W. (1982) Cerebro-Hepato-Renal (Zellweger) Syndrome and Neonatal Adrenoleukodystrophy: Similarities in Phenotype and Accumulation of Very Long Chain Fatty Acids, Johns Hopkins Med. J. 151, 344-361.
4. Singh, I., Moser, A.B., Goldfischer, S., and Moser, H.W. (1984) Lignoceric Acid Is Oxidized in the Peroxisome: Implications for the Zellweger Cerebro-Hepato-Renal Syndrome and Adrenoleukodystrophy, Proc. Natl. Acad. Sci. USA 81, 4203-4207.
5. Heymans, H.S.A., Schutgens, R.B.H., Tan, R., van den Bosch, H., and Borst, P. (1983) Severe Plasmalogen Deficiency in Tissues of Infants Without Peroxisomes (Zellweger syndrome), Nature 306, 69-70.
6. Hajra, A.K., and Bishop, J.E. (1982) Glycerolipid Biosynthesis in Peroxisomes via the Acyl Dihydroxyacetone Phosphate Pathway, Ann. NY Acad. Sci. 386, 170-182.
7. Poulos, A., Sharp, P., Fellenberg, A.J., and Danks, D.M. (1985) Cerebro-Hepato-Renal (Zellweger) Syndrome, Adrenoleukodystrophy and Refsum's Disease; Plasma Changes and Skin Fibroblast Phytanic Acid Oxidase, Hum. Genet. 70, 172-177.
8. Hanson, R.F., Szczepanik-van Leeuwen, P., Williams, G.C., Grabowski, G., and Sharp, H.L. (1979) Defects of Bile Acids Synthesis in Zellweger's Syndrome, Science 203, 1107-1108.
9. Powers, J.M., and Moser, H.W. (1998) Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis, Brain Pathol. 8, 101-120.
10. Jaffe, R., Crumrine, P., Hashida, Y., and Moser, H.W. (1982) Neonatal Adrenoleukodystrophy: Clinical, Pathologic, and Biochemical Delineation of a Syndrome Affecting Both Males and Females, Am. J. Pathol. 108, 100-111.
11. Scotto, J.M., Hadchouel, M., Odievre, M., Landat, M.H., Saudubray, J.M., Dulac, O., Beucler, Y., and Beaune, P. (1982) Infantile Phytanic Acid Storage Disease, a Possible Variant of Refsum's Disease: Three Cases, Including Ultrastructural Studies of the Liver, J. Inher. Metab. Dis. 5, 83-90.
12. Moser, A.B., Rasmussen, M., Naidu, S., Watkins, P.A., McGuinness, M., Hajra, A.K., Chen, G., Raymond, G., Liu, A., Gordon, D., Gamaas, K., Walton, D.S., Skjeldal, O.H., Guggenheim, M.A., Jackson, L.G., Elias, E.R., and Moser, H.W. (1995) Phenotype of Patients with Peroxisomal Disorders Subdivided into Sixteen Complementation Groups, J. Pediatr. 125, 755-767.
13. Martinez, M. (1989) Polyunsaturated Fatty Acid Changes Suggesting a New Enzymatic Defect in Zellweger Syndrome, Lipids 24, 261-265.
14. Martinez, M. (1990) Severe Deficiency of Docosahexaenoic Acid in Peroxisomal Disorders: A Defect of D4 Desaturation? Neurology 40, 1292-1298.
15. Martinez, M. (1992) Abnormal Profiles of Polyunsaturated Fatty Acids in the Brain, Liver, Kidney and Retina of Patients with Peroxisomal Disorders, Brain Res. 583, 171-182.
16. Breckenridge, W.C., Gombos, G., and Morgan, I.G. (1972) The Lipid Composition of Adult Rat Brain Synaptosomal Plasma Membranes, Biochim. Biophys. Acta 266, 695-707.
17. Anderson, R.E., Benolken, R.M., Dudley, P.A., Landis, D.J., and Wheeler, T.G. (1974) Polyunsaturated Fatty Acids of Photoreceptor Membranes, Exp. Eye Res. 18, 205-213.
18. Martinez, M., and Mougan, I. (1998) Fatty Acid Composition of Human Brain Phospholipids During Normal Development, J. Neurochem. 71, 2528-2533.
19. Horrocks, L.A., and Sun, G.Y. (1972) Ethanolamine Plasmalogens, in Research Methods in Neurochemistry, Vol. 1 (Marks, N., and Rodnight, R., eds.), pp. 223-231, Plenum, New York.
20. Lepage, G., and Roy, C.C. (1986) Direct Transesterification of All Classes of Lipids in a One-Step Reaction, J. Lipid Res. 27, 114-120.
21. Martinez, M., Mougan, I., Roig, M., and Ballabriga, A. (1994) Blood Polyunsaturated Fatty Acids in Patients with Peroxisomal Disorders. A Multicenter Study, Lipids 29, 273-280.
22. Balazy, M., and Nies, A.S. (1989) Characterization of Epoxides of Polyunsaturated Fatty Acids by Mass Spectrometry via 3-Pyridinylmethyl Esters, Biomed. Environ. Mass Spectrom. 18, 1328-1336.
23. Martinez, M., Ballabriga, A., and Gil-Gibernau, J.J. (1988) Lipids of the Developing Human Retina: I. Total Fatty Acids, Plasmalogens, and Fatty Acid Composition of Ethanolamine and Choline Phosphoglycerides, J. Neurosci. Res. 20, 484-490.
24. Crawford, M.A., Casperd, N.M., and Sinclair, A.J. (1976) The Long-Chain Metabolites of Linoleic and Linolenic Acids in Liver and Brain in Herbivores and Carnivores, Comp. Biochem. Physiol. [B] 54, 395-401.
25. Svennerholm, L. (1968) Distribution and Fatty Acid Composition of Phosphoglycerides in Normal Human Brain, J. Lipid Res. 9, 570-579.
26. Jones, C.R., Arai, T., and Rapoport, S.I. (1997) Evidence for the Involvement of Docosahexaenoic Acid in Cholinergic Stimulated Signal Transduction at the Synapse, Neurochem. Res. 22, 663-670.
27. Martinez, M. (1998) Docosahexaenoic Acid Ethyl Ester as a Treatment for Patients with Generalized Peroxisomal Disorders, in Lipids in Infant Nutrition (Huang, Y.S., and Sinclair, A.J., eds.), pp. 29-38. AOCS Press, Champaign.
28. Martinez, M., and Vázquez, L. (1998) Treatment with Docosahexaenoic Acid Ethyl Ester Improves Myelination in Patients with Generalized Peroxisomal Disorders, Neurology 51, 26-32.
29. Kanada, E., and Suzuki, K. (1980) Specificity of Galactosylceramidase Activation by Phosphatidylserine, Biochim. Biophys. Acta 619, 396-402.
30. Hajra, A.K., Bowen, D.M., Kishimoto, Y., and Radin, N.S. (1966) Cerebroside Galactosidase of Brain, J. Lipid Res. 7, 379-386.